http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA05000729-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05ff905fdc49089f5f25746eaeb40190 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2003-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1877f92d767adac5a42bbed42c644171 |
| publicationDate | 2005-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-PA05000729-A |
| titleOfInvention | COMBINATION OF AN ALOSTERIC METALOPROTEINASA-13 MATRIX INHIBITOR WITH CELECOXIB OR VALDECOXIB. |
| abstract | This invention provides a combination comprising an MMP-13 allosteric inhibitor, or a pharmaceutically acceptable salt thereof, with celecoxib or a pharmaceutically acceptable salt thereof, or valdecoxib or a pharmaceutically acceptable salt thereof; this invention also provides a method for treating a disease that responds to the inhibition of MMP-13 and cyclooxygenase-2, which comprises administering the combination of the invention to a patient suffering from said disease; This invention also provides a pharmaceutical composition comprising the combination of the invention and a pharmaceutically acceptable carrier, diluent, or excipient; the combination of the invention can also be combined with other pharmaceutical agents, depending on the disease being treated. |
| priorityDate | 2002-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 749.